Forma Life Science Marketing Blog filter by tag: CRO

When Tighter Regulatory Scrutiny Leads to Better Lifescience Marketing, Something is Seriously Wrong

February 11, 2010 at 9:34 AM by David Chapin

When the FDA monitors marketing claims VERY closely (for example, when marketing a pill, potion or med device) the result can be some very effective marketing (e.g, Advair, Viagra, etc.). On the other hand, there are cases in which the FDA is concerned not with marketing claims but only with the work product (e.g., labs, CROs and service providers that have to submit data to their sponsors and the FDA).

read more...

Tags: Commodity Positioning DTC Audience CRO